1 / 8

Cold Chain Logistics Opportunities for the Vaccines Industry

The latest research report "Healthcare Cold Chain Logistics Market and forecast 2016-2020" described the opportunities of Cold Chain Logistics Services in the vaccines sector. Link to report : http://www.imarcgroup.com/healthcare-cold-chain-logistics-market/

ImarcGroup
Download Presentation

Cold Chain Logistics Opportunities for the Vaccines Industry

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Imarc www.imarcgroup.com Consulting Services New Report Analyses the Cold Chain Logistics Opportunities for the Vaccines Industry Published : May 2015 Copyright © 2015International Market Analysis Research & Consulting (IMARC). All Rights Reserved Contact US IMARC Group Email: Sales@imarcgroup..com Website: www.imarcgroup.com Phone: (US)+1-631-791-1145, (IND) 91-120-415-5099  Buy Now Request Sample Enquiry

  2. About IMARC Group The International Market Analysis Research and Consulting Group is a leading advisor on management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise. IMARC’s tailored approach combines unfathomable insight into the dynamics of companies and markets with close cooperation at all levels of the client organization. This ensures that our clients achieve unmatchable competitive advantage, build more proficient organizations, and secure lasting results.

  3. New Report Analyses the Cold Chain Logistics Opportunities for the Vaccines Industry The extensive packaging, storage and transport of vaccines in controlled temperature conditions across the world is currently creating huge opportunities for the cold chain logistic services Industry. The global market for healthcare products (biopharmaceuticals, vaccines and clinical trial materials) requiring cold chain services is currently experiencing strong growth rates. According to IMARC Group’s new report, “Global Healthcare Cold Chain Logistics Market Report and Forecast (2016-2020)” this market reached a value of US$ 238 Billion in 2014 and is creating huge opportunities for cold chain logistic providers. Report Description and Highlights

  4. Vaccines Industry Vaccines Industry

  5. Report Description and Highlights The healthcare cold chain services industry comprises of packaging, storage, monitoring and transportation of temperature sensitive products. One of the biggest drivers of this market is the vaccines sector which has been witnessing strong double digit growth rates over the past several years. According to an analyst at IMARC Group “the production of vaccines is concentrated mostly in Europe, North America and a few Asian countries, whereas its consumption is diversified across the world. Thus the global vaccine supply chain involves a lot of movement with exports from a few manufacturing countries and imports to across the world which lack manufacturing capabilities”. The report also finds that all vaccines are sensitive to heat, freezing and light and must be kept at temperatures between +2˚C to +8˚C. The cold chain process in vaccines begins from the time it is manufactured and ends when it is administered to the recipient. This extensive packaging, storage and transport of vaccines across the world is currently creating huge opportunities for the cold chain logistic services Industry. IMARC Group’s latest report titled “Global Healthcare Cold Chain Logistics Market Report and Forecast (2016-2020)” has analysed the cold chain logistic services opportunities not only in the vaccines sector but also in clinical trial materials and biopharmaceuticals. This report provides an insight into the market trends, market segments, region breakup, challenges, global trade scenario and the key players in the healthcare cold chain logistics industry. The report, which is based on both desk based research and multiple waves of primary research is a must read for anyone who plans to venture into the healthcare cold chain logistics services industry. To know more on Healthcare Cold Chain Logistics Industry visit:http://www.imarcgroup.com/healthcare-cold-chain-logistics-market

  6. Report Description and Highlights To buy the complete report or to get a free sample, please contact: IMARC Group Asia: Email: apac@imarcgroup.comPhone: +91-120-415-5099  IMARC Group North America: Email: america@imarcgroup.comPhone: +1-631-791-1145 IMARC Group Europe, Middle East & Africa: Email: ema@imarcgroup.comPhone: +44-702-409-7331  To know more please visit:http://www.imarcgroup.com/healthcare-cold-chain-logistics-market

  7. Browse Related Reports: Pharmaceutical Contract Packaging Plant Project Report: Industry Trends, Manufacturing Process, Machinery, Raw Materials, Cost and Revenue - http://www.imarcgroup.com/pharmaceutical-contract-packaging-plant Biosimilar/Follow-on Biologics Market Report & Forecast: A Focus on the US (2011-2020) -http://www.imarcgroup.com/biosimilar-market Global Biopharmaceutical Market Report (2012-2017) - http://www.imarcgroup.com/biotechnology-industry

  8. © 2015 IMARC All Rights Reserved This Publication and all it’s contents unless otherwise mentioned are copyrighted in the name of International Market Analysis Research and Consulting (IMARC). No part of this publication may be reproduced, repackaged, redistributed or resold in whole or in any part. The publication may also not be used in any form or by and means graphic electronic or mechanical, including photocopying, recording, taping or by information storage or retrieval, or by any other form, without the express consent of International Market Analysis Research and Consulting (IMARC). Disclaimer: All contents and data of this publication, including forecasts, data analysis and opinion have been based on information and sources believed to be accurate and reliable at the time of publishing. International Market Analysis Research and Consulting makes no representation of warranty of any kind as to the accuracy or completeness of any Information provided. IMARC accepts no liability whatsoever for any loss or damage resulting from opinion, errors or inaccuracies if any found this publication. IMARC, IMARC Group and Global Therapy Insight Series are registered trademarks of International Market Analysis Research and Consulting. All other trademarks used in this publication are registered trademarks of their respective companies.

More Related